Join Edie and Regina James for a discussion on:

- Why clinical trial diversity is important;
- Federal regulations around promoting clinical trial diversity;
- 3 important tenets of achieving clinical trial diversity;
- How COVID-19 is moving the needle closer to a broader adaptation for virtual trials, therefore increasing the likelihood of trial diversity;
- Leveraging health information technology, telemedicine, and mobile apps to enhance trial diversity.